Immunological privilege in the eye: A review

References

• Greene H. S.N. The use of the mouse eye in transplantation experiments. Cancer Res 1947; 7: 491–501
   Web of Science ®Google Scholar
• Browning H. C. Homologous and heterologous growth of transplants of various tissues during the course of development in the mouse. Cancer 1949; 2: 646–672
   PubMed Web of Science ®Google Scholar
• Woodruff M. F.A. The transplantation of homologous tissue and its surgical application. Ann. Roy. Coll. Surg. Eng. 1952; 11: 173–194
   PubMed Web of Science ®Google Scholar
• Raju S., Grogan J. B. Immunology of the anterior chamber of the eye. Transplant. Proc 1971; 3: 605–608
   PubMed Web of Science ®Google Scholar
• Kaplan H. J., Streilein J. W. Do immunologically privileged site require a functioning spleen?. Nature 1974; 251: 553–554
   PubMed Web of Science ®Google Scholar
• Niederkorn J. Y., Streilein J. W. Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed type hypersensitivity but normal cytotoxic T lymphocyte and helper T lymphocyte responses. J. Immunol. 1983; 131: 2670–2674
   PubMed Web of Science ®Google Scholar
• Kaplan H. J., Streilein J. W. Analysis of immunologic privilege within the anterior chamber of the eye. Transplant. Proc 1977; 9: 1193–1195
   PubMed Web of Science ®Google Scholar
• Niederkorn J., Streilein J. W., Shadduck J. A. Deviant immune responses to allogeneic tumors injected intracamerally and subcuta-neously in mice. Invest. Ophthalmol. Vis. Sci. 1981; 10: 355–363
   Google Scholar
• Whittum J. A., Niederkorn J. Y., McCulley J. P., Streilein J. W. Intracameral inoculation of herpes simplex virus type I induces anterior chamber associated immune deviation. Curr. Eye Res. 1982; 2: 691–697
   PubMed Web of Science ®Google Scholar
• Wetzig R. P., Foster C. S., Greene M. I. Ocular immune responses.I. Priming of A/J mice in the anterior chamber with azobenzen-earsonate-devitalised cells induces second order-like suppressor cells. J. Immunol. 1982; 128: 1753–1757
   Google Scholar
• Waldrep J. C., Kaplan H. J. Cyclophosphamide-sensitive contrasup-pression in TNP-anterior chamber associated immune deviation (TNP-ACAID). J. Immunol. 1983; 131: 2746–2750
   PubMed Web of Science ®Google Scholar
• Waldrep J. C., Kaplan H. J. Anterior chamber-associated immune deviation induced by TNP-splenocytes (TNP-ACAID) II. Suppressor T-cell networks. Invest. Ophthalmol. Vis. Sci. 1983; 24: 1339–1345
   PubMed Web of Science ®Google Scholar
• Granstein R. D., Greene M. I. Splenic I-J bearing antigen presenting cells in activation of suppression: further characterization. Cell. Immunol. 1985; 91: 12–20
   PubMed Web of Science ®Google Scholar
• Liew F. Y., Scott M. T., Liu D. S., Croft S. L. Suppressive substance produced by T cells from mice chronically infected with Trypanosoma cruzi. I. Preferential inhibition of the induction of de-layed-type hypersensitivity. J. Immunol. 1987; 139: 2452–2457
   Google Scholar
• Green D. R., Wang N., Zheng H. A suppressor-inducer factor produced by burn trauma associated T cells. J. Burn Care Rehab. 1987; 8: 521–526
   PubMedGoogle Scholar
• Ferguson T. A., Kaplan H. J. The immune response and the eye.I. The effect of monoclonal antibodies to T suppressor factors in anterior chamber-associated immune deviation (ACAID). J. Immunol. 1987; 139: 346–351
   Google Scholar
• Ferguson T. A., Waldrep J. C., Kaplan H. J. The immune response and the eye.II. The nature of T suppressor cell induction in anterior chamber- associated immune deviation (ACAID). J.Immunol. 1987; 139: 352–357
   Google Scholar
• Niederkorn J. Y., Waltenbaugh C., Streilein J. W. Abrogation of anterior chamber-induced suppression of delayed-type hypersensitivity responses by monoclonal anti-I-J antibodies. Transplantation 1984; 37: 623–625
   PubMed Web of Science ®Google Scholar
• Ferguson T. A., Kaplan H. J. Genetic restrictions and cellular interactions in the induction of anterior chamber associated immune deviation (ACAID). Regional Immunol 1988; 1: 62–68
   PubMedGoogle Scholar
• Streilein J. W., Niederkorn J. Y. Induction of anterior chamber-associated immune deviation requires an intact, functional spleen. J. Exp. Med. 1981; 153: 1058–1067
   PubMed Web of Science ®Google Scholar
• Abi-Hanna D., Wakefield D., Watkins S. HLA Antigens in ocular tissue.I. In vivo expression in human eyes. Transplantation 1987; 45: 610–613
   Google Scholar
• Bakker M., Kijlstra A. The expression of HLA-antigens in the human anterior uvea. Curr. Eye Res. 1985; 4: 599–604
   PubMed Web of Science ®Google Scholar
• Kaiser C. J., Ksander B., Streilein J. W. Inhibition of lymphocyte proliferative responses to alloantigens by aqueous humor. Invest. Ophthalmol. Vis. Sci. 1987; 28: 41, suppl
   Google Scholar
• Kaplan H. J., Streilein J. W. Immune response to immunization via the anterior chamber of the eye. II. An analysis of F1 lymphocyte induced immune deviation. J. Immunol. 1978; 120: 689–693
   PubMed Web of Science ®Google Scholar
• Caspi R. R., Roberge F. G., Nussenblatt R. B. Organ resident, nonlymphoid cells suppress proliferation of autoimmune T-helper lymphocytes. Science 1987; 237: 1029–1032
   PubMed Web of Science ®Google Scholar
• Young E., Lutty G. A. Modulation of human lymphocyte proliferation by normal bovine vitreous. Invest. Ophthalmol. Vis. Sci. 1987; 28: 753–756
   PubMed Web of Science ®Google Scholar
• Niederkorn J. Y., Streilein J. W. Lymphoma allografts abrogate immun privilege within the anterior chamber of the eye. Invest. Ophthalmol. Vis. Sci. 1986; 27: 1235–1243
   PubMed Web of Science ®Google Scholar
• Cleveland R. P., Claman H. N. T cell signals: tolerance to DNFB is converted to sensitization by a separate non specific second signal. J. Immunol. 1980; 124: 474–480
   PubMed Web of Science ®Google Scholar
• Malkovsky M., Medewar P. B. Is immunological tolerance (non-responsiveness) a consequence of interleukin-2 deficit during the recognition of antigen? Immunol. Today 1984; 5: 340–343
   Google Scholar
• Niederkorn J. Y. Exogenous recombinant interleukin-2 abrogates anterior chamber associated immune deviation. Transplantation 1987; 30: 523–528
   Google Scholar